Monday, June 10, 2024

Exploring Mining Podcast with Chris Timmins of Pegasus Resources Inc. (TSXV: PEGA) (OTCQB: SLTFF) update with historic drilling data; @pegasusresinc

Exploring Mining Podcast with Chris Timmins of Pegasus Resources Inc. (TSXV: PEGA) (OTCQB: SLTFF) update with historic drilling data; @pegasusresinc

CEO Chris Timmins Discusses Latest press release on Historic data and Upcoming drill program for Energy Sands Project

June 8, 2024 (Investorideas.com Newswire) Investorideas.com, a global investor news source covering mining and metals stocks releases today's Exploring Mining Podcast, featuring a follow-up interview with Chris Timmins, CEO and President of Pegasus Resources Inc. (TSXV: PEGA) (OTCQB: SLTFF).

Listen to the podcast on Investorideas.com

https://www.investorideas.com/Audio/Podcasts/2024/060824-Mining.mp3

Watch the episode on YouTube:

https://www.youtube.com/watch?v=AHdD1ERvCdw

Listen to Exploring Mining podcast on iTunes Apple podcasts

Listen to Exploring Mining on Spotify

Paid dissemination on behalf of Pegasus Resources Inc.

In this episode, host Cali Van Zant talks to Chris Timmins about the historic data acquired, and consistencies and trends on their Energy Sands project (Full company press release here). Chris discusses what this means for permitting and updated targets for drilling this summer.

Read this in full at https://www.investorideas.com/news/2024/exploring-mining/06081Chris-Timmins-of-Pegasus-Resources-PEGA.asp

Full company press release https://www.pegasusresourcesinc.com/latest

About Pegasus Resources Inc

Pegasus Resources Inc. is a diversified Junior Canadian Mineral Exploration Company with a focus on uranium, gold, and base metal properties in North America. The Company is also actively pursuing the right opportunity in other resources to enhance shareholder value. For additional information, please visit the Company at www.pegasusresourcesinc.com

About the Energy Sands Project

The Energy Sands project consists of 100% owned 78 lode claims covering 1,560 acres in the San Rafael Uranium District of Utah approximately 4 kilometres from the San Rafael Uranium Project of Western Uranium and Vanadium.

Utah is ranked among the top 5 most favorable jurisdictions in the United States and is home to two built uranium mills and a third soon to be built by Western Uranium and Vanadium, which gives the companies operating in the area an exceptional advantage for future ore processing for conventional mining projects.

Historical small-scale production, between 1953 and 1956, totaling 103,600 Pounds at a grade of 0.373% U3O8 and 1.10% V2O5.
4 Corners Mines road runs through the property and connects to Interstate 70 (less 2km away), a mainline route of the Interstate Highway System in the United States connecting Utah and Maryland.

https://www.pegasusresourcesinc.com/energysands

Check out Pegasus Resources profile page on InvestorIdeas

https://www.investorideas.com/CO/PEGA/

The Investorideas.com podcasts are also available on Apple Podcasts, Audible, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts and most audio platforms available.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Research mining stocks at Investorideas.com with our mining stocks directory at Investorideas.com https://www.investorideas.com/Gold_Stocks/Stocks_List.asp

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for sectors including mining, crypto, renewable energy, gaming, biotech, tech, sports and more. Public companies within the sectors we cover can use our news publishing and content creation services to Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors.

Disclaimer/Disclosure: Pegasus Resources Inc. is a paid featured mining stock on Investorideas.com Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. Contact management and IR of each company directly regarding specific questions. Pegasus Resources Inc. is a paid featured mining stock on Investorideas.com More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Facebook https://www.facebook.com/Investorideas

Contact Investorideas.com to be a guest or sponsor this podcast

800-665-0411

Get more mining stock investor ideas- news, articles, podcasts and stock directories

Virus Treatments as Bird Flu Make Headlines (NASDAQ: $AEMD) (NASDAQ: $MRNA) (NYSE: $PFE) (NASDAQ: $IBRX) (NASDAQ: $ALGS) @moderna_tx @pfizer @ImmunityBio @AligosThera

Virus Treatments as Bird Flu Make Headlines (NASDAQ: $AEMD) (NASDAQ: $MRNA) (NYSE: $PFE) (NASDAQ: $IBRX) (NASDAQ: $ALGS) @moderna_tx @pfizer @ImmunityBio @AligosThera

June 10, 2024 - Investorideas.com, a go-to investing platform, releases the second of a two-part series looking at news and developments for the treatment of viruses, featuring Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases.

The threat of viruses is back in the news with multiple news sources, including the Guardian reporting, ”The World Health Organization (WHO) has said a man’s death in Mexico was caused by a strain of bird flu called H5N2 that has never before been found in a human.”

The WHO said Wednesday it wasn’t clear how the person became infected. “Although the source of exposure to the virus in this case is currently unknown, A (H5N2) viruses have been reported in poultry in Mexico,” it said in a statement.

Continued: “Scientists are on alert for changes in the virus that could signal that bird flu is adapting to spread more easily among humans.

Continued: “But the UN agency said Wednesday said the current risk of the bird flu virus to the general population in Mexico is low.”

With global populations and economies still feeling the impact of Covid-19, any virus threat is going to make headlines.

As viruses make headlines, companies are seeking solutions and not all are focused on vaccine development.

This news is paid advertisement/ news disseminated on behalf of/issued on behalf of Aethlon Medical Inc.

Read this article featuring AEMD in full at https://www.investorideas.com/news/2024/biotech/06101Virus-Treatments-Bird-Flu.asp

Aethlon Medical, Inc. (Nasdaq: AEMD) just recently announced an update on its technology for cancer treatment on its planned phase 1 safety, feasibility and dose-finding clinical trials of its Hemopurifier® in patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment, such as Keytruda® or Opdivo®.

The Aethlon Hemopurifier® technology is designed for the rapid depletion of cancer-promoting exosomes and circulating viruses. The United States Food and Drug Administration (FDA) has designated the Hemopurifier® as a “Breakthrough Device” for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease; and life-threatening viruses that are not addressed with approved therapies.

As reported previously, separate from its current focus on cancer treatment, Aethlon has investigated the potential for the use of the Hemopurifier® in viral diseases.

According to their SEC filing, “We also believe the Hemopurifier can be part of the broad-spectrum treatment of life-threatening highly glycosylated, or carbohydrate coated, viruses that are not addressed with an already approved treatment. In small-scale or early feasibility human studies, the Hemopurifier has been used in the past to treat individuals infected with human immunodeficiency virus, or HIV, hepatitis-C and Ebola.”

“Additionally, in vitro, the Hemopurifier has been demonstrated to capture Zika virus, Lassa virus, MERS-CoV, cytomegalovirus, Epstein-Barr virus, Herpes simplex virus, Chikungunya virus, Dengue virus, West Nile virus, smallpox-related viruses, H1N1 swine flu virus, H5N1 bird flu virus, Monkeypox virus and the reconstructed Spanish flu virus of 1918. In several cases, these studies were conducted in collaboration with leading government or non-government research institutes.”

Recently, Zacks reported that “Vaccine Stocks Rise on Growing Threat of Bird Flu Infections”

“Shares of several vaccine makers soared after reports suggest that the Biden administration is in discussions with Moderna (NASDAQ: MRNA) and Pfizer (NYSE:PFE) to set up a possible vaccine program aimed at preventing the spread of the H5N1 virus, also known as bird flu, in humans.”

Continued: “These reports came to light after the discovery of two cases of H5N1 virus in dairy farm workers in Texas and Michigan this year. Both these workers experienced symptoms in the eye after coming into contact with dairy cows infected with the H5N1 virus.”

But the treatment of viral diseases has other options including immunotherapy.

ImmunityBio (NASDAQ: IBRX), a clinical-stage immunotherapy company, announced earlier this year the publication of preclinical data in the online issue of Science, First Release indicating that combination therapy with N-803, an IL-15 superagonist, and broadly neutralizing antibodies may potentially enable the immune system to manage human immunodeficiency virus (HIV) without the need for antiretroviral treatment.

From the news: In the preclinical non-human primate study, researchers led by Dr. James Whitney, Ph.D. and funded by the National Institutes of Health and the National Institute of Allergy and Infectious Diseases (NIAID) demonstrated that using N-803, in combination with broadly neutralizing antibodies (bNAbs), led to sustained viral control after discontinuation of antiretroviral therapy (ART) in ART-suppressed rhesus macaques infected with simian-human immunodeficiency virus AD8 (SHIV-AD8). Treatment with N-803 and bNAbs led to immune activation and transient viremia, but only limited reductions in the SHIV reservoir. Upon ART discontinuation, all animals experienced viral rebound, followed by long-term virus control for up to 10 months in approximately 70% of those treated with N-803 and bNAbs.

"The viral reservoir in people with HIV is established within the first few days of infection and cannot be eliminated by the body’s immune system or currently available treatments, representing a significant obstacle in curing an established HIV infection," said James B. Whitney, M.D., Study Author and Researcher at the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center and Harvard Medical School. "When combined with broadly neutralizing antibodies, N-803 has the potential to provide viral control without significant reduction in the viral reservoir, which further suggests that the complete eradication of this reservoir may not be required to induce sustained remission after discontinuing antiretroviral therapy."

Taking another approach to viral diseases, Aligos Therapeutics, Inc. (NASDAQ: ALGS) is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of liver and viral diseases. Aligos’ strategy is to harness the deep expertise and decades of drug development experience its team has in liver and viral diseases to discover and develop potentially best-in-class therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) and viruses with high unmet medical need such as hepatitis B and coronaviruses.

The Company just announced positive data from six poster presentations at the European Association for the Study of the Liver (EASL) Congress 2024, being held June 5-8 in Milan, Italy.

From the news: Reported for the first time were antiviral and safety data in HBeAg-negative CHB subjects who received a daily single dose of 300 mg ALG-000184 monotherapy for ≤60 weeks. In all 11 subjects (100%), complete suppression of HBV DNA (<LLOQ 10 IU/mL) and RNA (<LLOQ 10 copies/mL) were noted, with reduction in HBcrAg levels indicating inhibition of HBV replication, as well as inhibition of cccDNA establishment/replenishment. In both patient populations, ALG-000184 continues to be well tolerated with no viral breakthrough.

With bird flu cases on the rise, retail investors are once again on the hunt for stocks with potential solutions.

As Bloomberg reported recently,”Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock in vaccine developers. It’s a familiar setup for industry veterans who have witnessed past trading frenzies at the first signs of an outbreak.”

This won’t be the last viral outbreak. There are more viruses than stars in the universe. And there are multiple solutions to treating viruses in addition to vaccines.

Read part one of the series at Investorideas.com

https://www.investorideas.com/news/2024/biotech/06031Blood-Purification-Medical-Devices.asp

Research biotech and medical device/ tech stocks at Investorideas.com

https://www.investorideas.com/BIS/Stock_List.asp

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for sectors including mining, crypto, renewable energy, gaming, biotech, tech, sports and more. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Paid content is always disclosed.

Disclaimer/Disclosure: This news article featuring AEMD is a paid for news release on Investorideas.com. AEMD is a paid featured medical tech stock on our site. Our site does not make recommendations for purchases or sale of stocks, services or products. This is not investment opinion: Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services and prices on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Contact Investorideas.com

800-665-0411

Biotech Industry Stocks- investing ideas in biotechnology stocks, medical technology and life sciences

Get more biotech and medical tech news, articles, podcasts and stock directories

Friday, June 07, 2024

May Nasdaq IPOs; (NYSE: $IBTA) (Nasdaq: $JUNE) (Nasdaq: $RAY) (Nasdaq: $HDL)

May Nasdaq IPOs; (NYSE: $IBTA) (Nasdaq: $JUNE) (Nasdaq: $RAY) (Nasdaq: $HDL)

Canadian IPO’s in Mining: (TSXV: $ORCL.V) (CSE: $ARGL.CN)

June 7, 2024 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today’s roundup of stocks – all recent IPO’s.

Read this in full at: https://www.investorideas.com/news/2024/main/06071Stocks.asp

The newest companies entering the Nasdaq markets are involved in digital media, home décor and maintenance services, personal care electronic products and a Chinese cuisine restaurant brand.

The latest Canadian listed IPOs are both mining companies.

Investor Ideas is always researching and searching for new stocks to add to our growing list of free stock directories. The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.”

New Stocks Added to the Tech Directories:

Ibotta, Inc. (NYSE:IBTA) is a leading performance marketing platform allowing brands to deliver digital promotions to over 200 million consumers through a network of publishers called the Ibotta Performance Network (IPN). The IPN allows marketers to influence what people buy, and where and how often they shop – all while paying only when their campaigns directly result in a sale. American shoppers have earned over $1.8 billion through the IPN since 2012. The largest tech IPO in history to come out of Colorado, Ibotta is headquartered in Denver, and is continually listed as a top place to work by The Denver Post and Inc. Magazine.

New Stocks Added to the Homebuilder Directories:

Junee Ltd (Nasdaq:JUNE) and its wholly-owned subsidiary, OPS Interior Design Consultant Limited ("OPS HK"), provides quality interior design, fit-out and maintenance services to both residential and commercial clients in the Hong Kong interior design market. The interior design service involves preliminary consulting services, conceptualizing clients' design ideas with layout plans, and producing detailed design drawings. Fit-out work generally includes any activities making an interior space suitable for residential or commercial purposes. OPS HK also provides a broad range of repair and maintenance services, including routine home condition upkeep services. OPS HK won the Muse Design Award in 2020, and was the given Most Valuable Companies in Hong Kong Award 2020 by Mediazone.

New Stocks Added to the Retail Directories:

Raytech Holding Ltd (Nasdaq:RAY) is a Hong Kong-headquartered company with over 10 years of experience in the personal care electrical appliance industry. Through its operating subsidiary in Hong Kong, it sources and wholesales a diverse range of personal care electrical appliances ranging from hair styling, tooling, trimmer, eyelash curler, neck care, to nail care and other body and facial care appliances for international brand owners, providing integrated product design, production processing, and manufacturing solutions.

New Stocks Added to the Food & Beverage Directories:

SUPER HI INTERNATIONAL HOLDING LTD. (Nasdaq:HDL) is a leading Chinese cuisine restaurant brand, operating Haidilao hot pot restaurant in the international market. With roots in Sichuan from 1994, Haidilao has become one of the most popular and largest Chinese cuisine brands in the world. With almost 30 years of brand history, Haidilao is well-loved by guests for its unique dining experience — warm and attentive service, great ambiance and delicious food, standing out among global restaurant chains, which has made Haidilao restaurants into a worldwide cultural phenomenon. As of March 31, 2024, Super Hi had 119 self-operated restaurants in 13 countries across four continents, making it the largest Chinese cuisine restaurant brand in terms of number of countries covered by self-operated restaurants.

New Stocks Added to the Mining Directories:

Oracle Commodity Holding Corp. (TSXV:ORCL) is a mining royalty company, a spin out from Silver Elephant Mining Corp. in 2022. Oracle's business is acquiring royalties on silver and critical minerals mining projects.

Argyle Resources Corp. (CSE:ARGL) is a junior mineral exploration company engaged in the business of acquiring, exploring, staking and evaluating natural resource properties in North America. The Company currently holds an option to acquire up to 100% of the Frenchvale Graphite Property located in Nova Scotia, Canada and an option to acquire up to 100% of the Wintering Lithium Property located in Ontario, Canada, which is not a mineral project material to the Company. The Company was incorporated in 2023 and its head office is located in Calgary, Alberta, Canada.

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for various sectors, including gaming, biotech, tech and sports. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Paid content is always disclosed.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

Contact Investorideas.com to be added to our stock directories or learn more about us

Dawn Van Zant and Cali Van Zant

800 665 0411

The Hunt for Virus Treatments Continues Post Covid-19 (NASDAQ: $AEMD) (NASDAQ: $MRNA) (NYSE: $PFE) (NASDAQ: $IBRX) (NASDAQ: $ALGS) @moderna_tx @pfizer @ImmunityBio @AligosThera

The Hunt for Virus Treatments Continues Post Covid-19 (NASDAQ: $AEMD) (NASDAQ: $MRNA) (NYSE: $PFE) (NASDAQ: $IBRX) (NASDAQ: $ALGS) @moderna_tx @pfizer @ImmunityBio @AligosThera

June 7, 2024 - Investorideas.com, a go-to investing platform, releases the second of a two-part series looking at news and developments for the treatment of viruses, featuring Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases.

This news is paid advertisement/ news disseminated on behalf of/issued on behalf of Aethlon Medical Inc.

Read this article featuring AEMD in full at https://www.investorideas.com/news/2024/biotech/06071Virus-Treatments-Post-Covid-19.asp

Continued: “Scientists are on alert for changes in the virus that could signal that bird flu is adapting to spread more easily among humans.

Continued: “But the UN agency said Wednesday said the current risk of the bird flu virus to the general population in Mexico is low.”

With global populations and economies still feeling the impact of Covid-19, any virus threat is going to make headlines.

As viruses make headlines, companies are seeking solutions and not all are focused on vaccine development.

As reported previously, separate from its current focus on cancer treatment, Aethlon has investigated the potential for the use of the Hemopurifier® in viral diseases.

Recently, Zacks reported that “Vaccine Stocks Rise on Growing Threat of Bird Flu Infections”

But the treatment of viral diseases has other options including immunotherapy.

The Company just announced positive data from six poster presentations at the European Association for the Study of the Liver (EASL) Congress 2024, being held June 5-8 in Milan, Italy.

With bird flu cases on the rise, retail investors are once again on the hunt for stocks with potential solutions.

This won’t be the last viral outbreak. There are more viruses than stars in the universe. And there are multiple solutions to treating viruses in addition to vaccines.

Read part one of the series at Investorideas.com

https://www.investorideas.com/news/2024/biotech/06031Blood-Purification-Medical-Devices.asp

Research biotech and medical device/ tech stocks at Investorideas.com

https://www.investorideas.com/BIS/Stock_List.asp

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for sectors including mining, crypto, renewable energy, gaming, biotech, tech, sports and more. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Paid content is always disclosed.

Contact Investorideas.com

800-665-0411

Biotech Industry Stocks- investing ideas in biotechnology stocks, medical technology and life sciences

Get more biotech and medical tech news, articles, podcasts and stock directories

About Investorideas.com

About Investorideas.com - Big Investing Ideas Investorideas.com is a platform for investing ideas. We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.

Disclaimer/disclosure

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas, Trading Ideas and Stocks to Watch

Monday, June 10, 2024

Exploring Mining Podcast with Chris Timmins of Pegasus Resources Inc. (TSXV: PEGA) (OTCQB: SLTFF) update with historic drilling data; @pegasusresinc

Virus Treatments as Bird Flu Make Headlines (NASDAQ: $AEMD) (NASDAQ: $MRNA) (NYSE: $PFE) (NASDAQ: $IBRX) (NASDAQ: $ALGS) @moderna_tx @pfizer @ImmunityBio @AligosThera

This news is paid advertisement/ news disseminated on behalf of/issued on behalf of Aethlon Medical Inc.

Recently, Zacks reported that “Vaccine Stocks Rise on Growing Threat of Bird Flu Infections”

Get more biotech and medical tech news, articles, podcasts and stock directories

Friday, June 07, 2024

May Nasdaq IPOs; (NYSE: $IBTA) (Nasdaq: $JUNE) (Nasdaq: $RAY) (Nasdaq: $HDL)

The Hunt for Virus Treatments Continues Post Covid-19 (NASDAQ: $AEMD) (NASDAQ: $MRNA) (NYSE: $PFE) (NASDAQ: $IBRX) (NASDAQ: $ALGS) @moderna_tx @pfizer @ImmunityBio @AligosThera

This news is paid advertisement/ news disseminated on behalf of/issued on behalf of Aethlon Medical Inc.

Recently, Zacks reported that “Vaccine Stocks Rise on Growing Threat of Bird Flu Infections”

Get more biotech and medical tech news, articles, podcasts and stock directories

Blog Archive

Links

Search This Blog